aluates Reports

$ 0.0

Automative

Global Canine Arthritis Treatment Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-28U11968

Global Canine Arthritis Treatment Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Canine Arthritis Treatment Market Research Report 2024

Code: QYRE-Auto-28U11968

Report

January 2024

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Elanco (Eli Lilly and Company)

Boehringer Ingelheim

Zoetis Inc

Vetoquinol

Bayer

Aratana Therapeutics Inc

Norbrook Laboratories Limited

VETSTEM BIOPHARMA

Dechra Pharmaceuticals Plc

Canine Arthritis Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Canine Arthritis Treatment Market

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.

The global Canine Arthritis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Canine Arthritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Arthritis Treatment.

Report Scope

The Canine Arthritis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Arthritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Canine Arthritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Canine Arthritis Treatment Market Report

Report Metric	Details
Report Name	Canine Arthritis Treatment Market
CAGR	5%
Segment by Type	Non-Steroidal Anti-Inflammatory Drugs Opioids
Segment by Application	Veterinary Hospitals and Clinics Drug Stores E-commerce
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma, Dechra Pharmaceuticals Plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Arthritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Canine Arthritis Treatment Market report?

Ans: The main players in the Canine Arthritis Treatment Market are Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma, Dechra Pharmaceuticals Plc

What are the Application segmentation covered in the Canine Arthritis Treatment Market report?

Ans: The Applications covered in the Canine Arthritis Treatment Market report are Veterinary Hospitals and Clinics, Drug Stores, E-commerce

What are the Type segmentation covered in the Canine Arthritis Treatment Market report?

Ans: The Types covered in the Canine Arthritis Treatment Market report are Non-Steroidal Anti-Inflammatory Drugs, Opioids

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Canine Arthritis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Non-Steroidal Anti-Inflammatory Drugs

1.2.3 Opioids

1.3 Market by Application

1.3.1 Global Canine Arthritis Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Veterinary Hospitals and Clinics

1.3.3 Drug Stores

1.3.4 E-commerce

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Canine Arthritis Treatment Market Perspective (2019-2030)

2.2 Canine Arthritis Treatment Growth Trends by Region

2.2.1 Global Canine Arthritis Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Canine Arthritis Treatment Historic Market Size by Region (2019-2024)

2.2.3 Canine Arthritis Treatment Forecasted Market Size by Region (2025-2030)

2.3 Canine Arthritis Treatment Market Dynamics

2.3.1 Canine Arthritis Treatment Industry Trends

2.3.2 Canine Arthritis Treatment Market Drivers

2.3.3 Canine Arthritis Treatment Market Challenges

2.3.4 Canine Arthritis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Canine Arthritis Treatment Players by Revenue

3.1.1 Global Top Canine Arthritis Treatment Players by Revenue (2019-2024)

3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Canine Arthritis Treatment Revenue

3.4 Global Canine Arthritis Treatment Market Concentration Ratio

3.4.1 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Treatment Revenue in 2023

3.5 Canine Arthritis Treatment Key Players Head office and Area Served

3.6 Key Players Canine Arthritis Treatment Product Solution and Service

3.7 Date of Enter into Canine Arthritis Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Canine Arthritis Treatment Breakdown Data by Type

4.1 Global Canine Arthritis Treatment Historic Market Size by Type (2019-2024)

4.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2025-2030)

5 Canine Arthritis Treatment Breakdown Data by Application

5.1 Global Canine Arthritis Treatment Historic Market Size by Application (2019-2024)

5.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Canine Arthritis Treatment Market Size (2019-2030)

6.2 North America Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Canine Arthritis Treatment Market Size by Country (2019-2024)

6.4 North America Canine Arthritis Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Canine Arthritis Treatment Market Size (2019-2030)

7.2 Europe Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Canine Arthritis Treatment Market Size by Country (2019-2024)

7.4 Europe Canine Arthritis Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Canine Arthritis Treatment Market Size (2019-2030)

8.2 Asia-Pacific Canine Arthritis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Canine Arthritis Treatment Market Size (2019-2030)

9.2 Latin America Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Canine Arthritis Treatment Market Size by Country (2019-2024)

9.4 Latin America Canine Arthritis Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Canine Arthritis Treatment Market Size (2019-2030)

10.2 Middle East & Africa Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Elanco (Eli Lilly and Company)

11.1.1 Elanco (Eli Lilly and Company) Company Detail

11.1.2 Elanco (Eli Lilly and Company) Business Overview

11.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Introduction

11.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2019-2024)

11.1.5 Elanco (Eli Lilly and Company) Recent Development

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Detail

11.2.2 Boehringer Ingelheim Business Overview

11.2.3 Boehringer Ingelheim Canine Arthritis Treatment Introduction

11.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2019-2024)

11.2.5 Boehringer Ingelheim Recent Development

11.3 Zoetis Inc

11.3.1 Zoetis Inc Company Detail

11.3.2 Zoetis Inc Business Overview

11.3.3 Zoetis Inc Canine Arthritis Treatment Introduction

11.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2019-2024)

11.3.5 Zoetis Inc Recent Development

11.4 Vetoquinol S.A.

11.4.1 Vetoquinol S.A. Company Detail

11.4.2 Vetoquinol S.A. Business Overview

11.4.3 Vetoquinol S.A. Canine Arthritis Treatment Introduction

11.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2019-2024)

11.4.5 Vetoquinol S.A. Recent Development

11.5 Bayer AG

11.5.1 Bayer AG Company Detail

11.5.2 Bayer AG Business Overview

11.5.3 Bayer AG Canine Arthritis Treatment Introduction

11.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2019-2024)

11.5.5 Bayer AG Recent Development

11.6 Aratana Therapeutics Inc

11.6.1 Aratana Therapeutics Inc Company Detail

11.6.2 Aratana Therapeutics Inc Business Overview

11.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Introduction

11.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2019-2024)

11.6.5 Aratana Therapeutics Inc Recent Development

11.7 Norbrook Laboratories Limited

11.7.1 Norbrook Laboratories Limited Company Detail

11.7.2 Norbrook Laboratories Limited Business Overview

11.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Introduction

11.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2019-2024)

11.7.5 Norbrook Laboratories Limited Recent Development

11.8 VetStem Biopharma

11.8.1 VetStem Biopharma Company Detail

11.8.2 VetStem Biopharma Business Overview

11.8.3 VetStem Biopharma Canine Arthritis Treatment Introduction

11.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2019-2024)

11.8.5 VetStem Biopharma Recent Development

11.9 Dechra Pharmaceuticals Plc

11.9.1 Dechra Pharmaceuticals Plc Company Detail

11.9.2 Dechra Pharmaceuticals Plc Business Overview

11.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Introduction

11.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2019-2024)

11.9.5 Dechra Pharmaceuticals Plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Elanco (Eli Lilly and Company)

Boehringer Ingelheim

Zoetis Inc

Vetoquinol

Bayer

Aratana Therapeutics Inc

Norbrook Laboratories Limited

VETSTEM BIOPHARMA

Dechra Pharmaceuticals Plc

List of Tables

Table 1. Global Canine Arthritis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs

Table 3. Key Players of Opioids

Table 4. Global Canine Arthritis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Canine Arthritis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Canine Arthritis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Canine Arthritis Treatment Market Share by Region (2019-2024)

Table 8. Global Canine Arthritis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Canine Arthritis Treatment Market Share by Region (2025-2030)

Table 10. Canine Arthritis Treatment Market Trends

Table 11. Canine Arthritis Treatment Market Drivers

Table 12. Canine Arthritis Treatment Market Challenges

Table 13. Canine Arthritis Treatment Market Restraints

Table 14. Global Canine Arthritis Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Canine Arthritis Treatment Market Share by Players (2019-2024)

Table 16. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2023)

Table 17. Ranking of Global Top Canine Arthritis Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Canine Arthritis Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Canine Arthritis Treatment Product Solution and Service

Table 21. Date of Enter into Canine Arthritis Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Canine Arthritis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Canine Arthritis Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Canine Arthritis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Canine Arthritis Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Canine Arthritis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Canine Arthritis Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global Canine Arthritis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Canine Arthritis Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Canine Arthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Canine Arthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Canine Arthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Canine Arthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Canine Arthritis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Canine Arthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Canine Arthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Elanco (Eli Lilly and Company) Company Detail

Table 47. Elanco (Eli Lilly and Company) Business Overview

Table 48. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product

Table 49. Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 50. Elanco (Eli Lilly and Company) Recent Development

Table 51. Boehringer Ingelheim Company Detail

Table 52. Boehringer Ingelheim Business Overview

Table 53. Boehringer Ingelheim Canine Arthritis Treatment Product

Table 54. Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 55. Boehringer Ingelheim Recent Development

Table 56. Zoetis Inc Company Detail

Table 57. Zoetis Inc Business Overview

Table 58. Zoetis Inc Canine Arthritis Treatment Product

Table 59. Zoetis Inc Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 60. Zoetis Inc Recent Development

Table 61. Vetoquinol S.A. Company Detail

Table 62. Vetoquinol S.A. Business Overview

Table 63. Vetoquinol S.A. Canine Arthritis Treatment Product

Table 64. Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 65. Vetoquinol S.A. Recent Development

Table 66. Bayer AG Company Detail

Table 67. Bayer AG Business Overview

Table 68. Bayer AG Canine Arthritis Treatment Product

Table 69. Bayer AG Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 70. Bayer AG Recent Development

Table 71. Aratana Therapeutics Inc Company Detail

Table 72. Aratana Therapeutics Inc Business Overview

Table 73. Aratana Therapeutics Inc Canine Arthritis Treatment Product

Table 74. Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 75. Aratana Therapeutics Inc Recent Development

Table 76. Norbrook Laboratories Limited Company Detail

Table 77. Norbrook Laboratories Limited Business Overview

Table 78. Norbrook Laboratories Limited Canine Arthritis Treatment Product

Table 79. Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 80. Norbrook Laboratories Limited Recent Development

Table 81. VetStem Biopharma Company Detail

Table 82. VetStem Biopharma Business Overview

Table 83. VetStem Biopharma Canine Arthritis Treatment Product

Table 84. VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 85. VetStem Biopharma Recent Development

Table 86. Dechra Pharmaceuticals Plc Company Detail

Table 87. Dechra Pharmaceuticals Plc Business Overview

Table 88. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product

Table 89. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2019-2024) & (US$ Million)

Table 90. Dechra Pharmaceuticals Plc Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Canine Arthritis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Canine Arthritis Treatment Market Share by Type: 2023 VS 2030

Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features

Figure 4. Opioids Features

Figure 5. Global Canine Arthritis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Canine Arthritis Treatment Market Share by Application: 2023 VS 2030

Figure 7. Veterinary Hospitals and Clinics Case Studies

Figure 8. Drug Stores Case Studies

Figure 9. E-commerce Case Studies

Figure 10. Canine Arthritis Treatment Report Years Considered

Figure 11. Global Canine Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Canine Arthritis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Canine Arthritis Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global Canine Arthritis Treatment Market Share by Players in 2023

Figure 15. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Canine Arthritis Treatment Revenue in 2023

Figure 17. North America Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Canine Arthritis Treatment Market Share by Country (2019-2030)

Figure 19. United States Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Canine Arthritis Treatment Market Share by Country (2019-2030)

Figure 23. Germany Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Canine Arthritis Treatment Market Share by Region (2019-2030)

Figure 31. China Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Canine Arthritis Treatment Market Share by Country (2019-2030)

Figure 39. Mexico Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Canine Arthritis Treatment Market Share by Country (2019-2030)

Figure 43. Turkey Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Canine Arthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Elanco (Eli Lilly and Company) Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 46. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 47. Zoetis Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 48. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 49. Bayer AG Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 50. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 51. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 52. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 53. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Treatment Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions